Periodontitis: Researchers search for a new active substance
Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous. It was developed and tested for the first time by a team from Martin Luther University Halle-Wittenberg (MLU), the Fraunhofer Institute for Cell Therapy and Immunology IZI and Periotrap Pharmaceuticals GmbH, a Fraunhofer IZI spin-off. The aim is to neutralise only bacteria that cause periodontitis while sparing harmless bacteria. The study appeared in the "Journal of Biological Chemistry".
For more information see the website of the Martin Luther University Halle-Wittenberg.